Masatsugu Ueda

Title: Masatsugu Ueda: Innovator in Osteoclastogenesis Inhibitory Factor Proteins

Introduction

Masatsugu Ueda is a prominent inventor based in Kawagoe, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of proteins that inhibit osteoclast differentiation and maturation. With a total of 12 patents to his name, Ueda's work has the potential to impact various medical applications.

Latest Patents

Ueda's latest patents focus on nucleic acid molecules encoding osteoclastogenesis inhibitory factor proteins. These proteins are crucial for inhibiting osteoclast differentiation and maturation. The proteins are produced by human embryonic lung fibroblasts and exhibit a molecular weight of approximately 60 kD and 120 kD under non-reducing conditions, and about 60 kD under reducing conditions on SDS-polyacrylamide gel electrophoresis. The proteins can be isolated and purified from the culture medium of fibroblasts, and they can also be produced through gene engineering. His inventions include cDNA for producing the protein, antibodies with specific affinity for the protein, and methods for determining protein concentration using these antibodies.

Career Highlights

Throughout his career, Ueda has worked with notable companies such as Sankyo Company, Limited and Snow Brand Milk Products Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and protein engineering.

Collaborations

Ueda has collaborated with several professionals in his field, including Masaaki Goto and Kanji Higashio. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in biotechnology.

Conclusion

Masatsugu Ueda's contributions to the field of osteoclastogenesis inhibitory factor proteins demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a key figure in biotechnology.